Pancreatic Cancer Research

ResearcherShanghai Medical College of Fudan UniversityNo recent work listed

Wang Jiang

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 7 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
15
Papers, trials and grants by year

2020: 3 papers · 2021: 1 paper

Papers 4

  1. Human splenic TER cells: A relevant prognostic factor acting via the artemin-GFRα3-ERK pathway in pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/ijc.33410↗
  2. TET1 downregulates epithelial-mesenchymal transition and chemoresistance in PDAC by demethylating CHL1 to inhibit the Hedgehog signaling pathway. First author DOI 10.1038/s41388-020-01407-8↗
  3. Haemoglobin, albumin, lymphocyte and platelet predicts postoperative survival in pancreatic cancer. Co-author DOI 10.3748/wjg.v26.i8.828↗
  4. Precise and efficient silencing of mutant Kras G12D by CRISPR-CasRx controls pancreatic cancer progression. Co-author DOI 10.7150/thno.46642↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xianjun Yu · 4 shared papers, 2020–2021 · strength 0.43
  2. Wuhu Zhang · 3 shared papers, 2020–2021 · strength 0.33
  3. Tianjiao Li · 3 shared papers, 2020–2021 · strength 0.33
  4. Shuo Li · 3 shared papers, 2020–2021 · strength 0.31
  5. Huaxiang Xu · 3 shared papers, 2020–2021 · strength 0.31
  6. Chuntao Wu · 3 shared papers, 2020–2021 · strength 0.31
  7. Liang Liu · 2 shared papers, 2020 · strength 0.22
  8. Heli Gao · 2 shared papers, 2020–2021 · strength 0.21
  9. Wenquan Wang · 2 shared papers, 2020–2021 · strength 0.21
  10. Liang Liu · 2 shared papers, 2020–2021 · strength 0.21
  11. Xuan Han · 2 shared papers, 2020–2021 · strength 0.21
  12. Hao Li · 2 shared papers, 2020–2021 · strength 0.21
  13. Wen-Quan Wang · 1 shared paper, 2020 · strength 0.10
  14. He-Li Gao · 1 shared paper, 2020 · strength 0.10
  15. Shuai-Shuai Xu · 1 shared paper, 2020 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.